CN116478126B - Preparation and application of A-D-A type organic micromolecular photosensitizer - Google Patents
Preparation and application of A-D-A type organic micromolecular photosensitizer Download PDFInfo
- Publication number
- CN116478126B CN116478126B CN202310292719.6A CN202310292719A CN116478126B CN 116478126 B CN116478126 B CN 116478126B CN 202310292719 A CN202310292719 A CN 202310292719A CN 116478126 B CN116478126 B CN 116478126B
- Authority
- CN
- China
- Prior art keywords
- photosensitizer
- receptor
- strong
- donor
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003504 photosensitizing agent Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 8
- 239000011737 fluorine Substances 0.000 claims abstract description 4
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000000460 chlorine Substances 0.000 claims abstract description 3
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract description 3
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 150000003384 small molecules Chemical class 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 239000012216 imaging agent Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 6
- 239000001301 oxygen Substances 0.000 abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 238000004220 aggregation Methods 0.000 abstract description 3
- 230000002776 aggregation Effects 0.000 abstract description 3
- 125000004429 atom Chemical group 0.000 abstract description 3
- QYFIFHYLFPTEOS-UHFFFAOYSA-N 1-oxoindene-2-carbonitrile Chemical compound C1=CC=C2C(=O)C(C#N)=CC2=C1 QYFIFHYLFPTEOS-UHFFFAOYSA-N 0.000 abstract description 2
- 238000000799 fluorescence microscopy Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000002428 photodynamic therapy Methods 0.000 abstract 1
- JLZUZNKTTIRERF-UHFFFAOYSA-N tetraphenylethylene Chemical group C1=CC=CC=C1C(C=1C=CC=CC=1)=C(C=1C=CC=CC=1)C1=CC=CC=C1 JLZUZNKTTIRERF-UHFFFAOYSA-N 0.000 abstract 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 abstract 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 6
- 238000000295 emission spectrum Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- POXIZPBFFUKMEQ-UHFFFAOYSA-N 2-cyanoethenylideneazanide Chemical group [N-]=C=[C+]C#N POXIZPBFFUKMEQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- YMWUJEATGCHHMB-DICFDUPASA-N dichloromethane-d2 Chemical compound [2H]C([2H])(Cl)Cl YMWUJEATGCHHMB-DICFDUPASA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004770 highest occupied molecular orbital Methods 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 230000002165 photosensitisation Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 description 1
- KIGVOJUDEQXKII-UHFFFAOYSA-N 4-bromo-n-(4-bromophenyl)-n-phenylaniline Chemical compound C1=CC(Br)=CC=C1N(C=1C=CC(Br)=CC=1)C1=CC=CC=C1 KIGVOJUDEQXKII-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical compound C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 230000001808 coupling effect Effects 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000005624 perturbation theories Effects 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- UGOMMVLRQDMAQQ-UHFFFAOYSA-N xphos Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 UGOMMVLRQDMAQQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/50—Photovoltaic [PV] energy
- Y02E10/549—Organic PV cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention belongs to the field of biomedical materials, and discloses preparation and application of a strong A-D-A type organic micromolecular photosensitizer. The invention is based on a receptor-donor-receptor configuration, having the structure shown below: Wherein: ar is aromatic heterocycle and its derivative, X is hydrogen element or fluorine element or chlorine element. The invention builds strong receptor-donor-receptor and strong charge transfer state and simultaneously inhibits the intermolecular pi-pi stacking effect of molecules in the aggregation state by introducing groups such as strong electron-withdrawing cyano indenone, derivative and the like at two ends of donor triphenylamine or tetraphenyl ethylene and derivative, thereby endowing the material with AIE characteristics. In addition, heavy atoms such as fluorine atoms or chlorine atoms are introduced, so that the energy gap crossing of the excited singlet state to the triplet state is promoted to realize efficient active oxygen generation. Based on the high-efficiency fluorescence quantum efficiency and ROS production capability, the material provided by the invention has a good application prospect in fluorescence imaging-mediated tumor photodynamic therapy.
Description
Technical Field
The invention belongs to the field of biomedical materials, and particularly relates to preparation and application of an A-D-A type organic micromolecular photosensitizer.
Background
The traditional photosensitizers mostly have planar structures and relatively poor water solubility, and are easy to cause dense pi-pi accumulation among molecules to cause excited state molecules to return to a ground state in a non-radiative transition mode of conversion, and the aggregated state not only can cause fluorescence quenching of the photosensitizers, but also can greatly reduce the photosensitizing efficiency of the photosensitizers. The discovery of the AIE phenomenon solves these problems well, and these AIE molecules not only have strong fluorescence in the aggregated state, but also have good photosensitizing efficiency. According to the perturbation theory, the method comprises the following steps, Enhancing spin-orbit coupling (SOC) or reducing the photosensitizer singlet (S 1) to singlet (T 1) bandgap difference (deltae ST) can facilitate intersystem crossing (ISC) of singlet (S 1) to singlet (T 1), Thereby enhancing the photosensitivity efficiency of the photosensitizer. Spin-orbit coupling is a function of electron spin and orbit magnetic quantum number, and the stronger the nuclear electropositivity, namely the heavier the atoms, the stronger the coupling effect of electron spin and orbit magnetic quantum number, so that connecting the photosensitizer with heavy atoms is the most direct way of promoting intersystem crossing and improving the photosensitizer efficiency. The difference in energy between S 1 and T 1 is simply due to the mutual exclusion of the two opposite spin-direction valence electrons in S 1 resulting in an energy above T 1, The mutual exclusion of electrons and the distance between two valence electrons are in a negative correlation, Separation of HOMO and LUMO in S 1 can effectively reduce the bandgap difference (Δe ST) from S 1 to T 1. The addition of electron-withdrawing groups to the molecular structure of the photosensitizer may promote the separation of the photosensitizer HOMO and LUMO, thereby reducing the energy gap difference from singlet S 1 to triplet T 1.
Disclosure of Invention
Aiming at the problems, the AIE material with high near infrared luminous efficiency, adjustable absorption and emission spectrum and good light stability is designed and synthesized, and the interference of self-absorption and autofluorescence of biological tissues is overcome. The preparation of the near infrared luminescent AIE material is realized based on the cyano-indenone skeleton. Meanwhile, the photodynamic efficiency is improved by a method of reducing the level difference of the singlet state and the triplet state, and the near-infrared AIE material with high luminous efficiency and high photodynamic activity is screened out.
In order to achieve the above purpose, the present invention provides the following technical solutions: A-D-A organic small molecule photosensitizer is prepared and application thereof, and the preparation method comprises the following steps:
In nitrogen atmosphere, adding an aldehyde group-containing strong electron donor compound and cyano-indidone into a reactor at a molar ratio of 1:3, adding chloroform as a solvent, adding a catalyst pyridine, stirring the mixture by a magnetic stirring device to dissolve the mixture, heating the mixture to 80 ℃ for reaction for 3 hours, decompressing and evaporating the solvent after the reaction is finished to obtain a crude product, and purifying the crude product by column chromatography to obtain the target compound.
The structure is I
Wherein X = fluorine or chlorine;
ar=an aromatic ring electron donating group, and is any one of the following groups.
The invention has the beneficial effects that:
1. The invention synthesizes a new photosensitizer material system with AIE performance to overcome the problem of the decrease of tumor treatment effect caused by the fluorescence aggregation quenching effect and tumor hypoxia of the existing photosensitizer.
2. The near infrared photosensitizer with AIE property provided by the invention has stronger total active oxygen generating capacity than commercial photosensitizer chlorin (Ce 6).
3. The near infrared photosensitizer with AIE property provided by the invention has the advantages of few synthesis steps, simple method and easily available raw materials.
4. The near infrared photosensitizer with AIE property provided by the invention can have good fluorescence imaging effect on in-vitro cells and living tumors; even under the condition of hypoxia, the composition can still have good killing performance on cancer cells; but also has high-efficiency cure to the living tumor of the mice.
Drawings
FIG. 1 is a normalized absorption spectrum of TPAPT-4F and 2TPAPT-4F in THF;
FIG. 2 is a graph showing the emission spectra of the obtained materials TPAPT-4F and 2TPAPT-4F in THF
FIG. 3 shows the total active oxygen generating capacity of TPAPT-4F and 2TPAPT-4F, and the photosensitizer Ce 6.
FIG. 4 (A) and FIG. 4 (C) are graphs showing the fluorescence spectra under different water contents, and the fluorescence intensities of TPAPT-4F and 2TPAPT-4F are significantly increased after gradually adding water to THF solution, FIG. 4 (B) and FIG. 4 (D) are graphs showing the relationship between I/I 0 of TPAPT-4F and 2TPAPT-4F and the water content of the solvent mixture
FIG. 5 is a mass spectrum of photosensitizer TPAPT-4F
FIG. 6 is a mass spectrum of photosensitizer 2TPAPT-4F
Detailed Description
The following technical solutions in the embodiments of the present invention will be clearly and completely described with reference to the accompanying drawings, so that those skilled in the art can better understand the advantages and features of the present invention, and thus the protection scope of the present invention is more clearly defined. The described embodiments of the present invention are intended to be only a few, but not all embodiments of the present invention, and all other embodiments that may be made by one of ordinary skill in the art without inventive faculty are intended to be within the scope of the present invention.
Example 1:
preparation of photosensitizer TPAPT-4F:
synthetic route for photosensitizer TPAPT-4F
Dibromotriphenylamine (0.4 g,0.99 mmol) (1), 5-aldehyde-2-thiopheneboronic acid (0.38 g,2.4 mmol), palladium acetate (0.012 g,0.05 mmol), X-Phos (0.04 g,0.08 mmol), potassium phosphate (1.72 g,7.9 mmol) were added to a mixture of 20mL tetrahydrofuran and water 1:1. After mixing and stirring uniformly, heating to 90 ℃ under the atmosphere of nitrogen, reacting for 12 hours, cooling to room temperature, and filtering the mixture to remove insoluble impurities. The mixture was then poured into water and extracted three times with dichloromethane. The combined organic layers were washed successively with saturated sodium bicarbonate and water, and then dried over anhydrous magnesium sulfate. After filtration, the solvent was evaporated under reduced pressure and the residue was purified by silica gel column chromatography. Yellow solid (2) was obtained in 45.7% yield (357 mg). 0.2g of the product and 5, 6-difluoro-3- (dicyanomethylene) indigonone (0.226 g,0.98 mmol) were weighed, a few drops of pyridine was added as a catalyst, reacted for 4 hours at 70 ℃, cooled to room temperature, the solvent was evaporated under reduced pressure, the appropriate chloroform was added for dissolution, a large amount of methanol was added to precipitate a solid, and the solid was filtered to obtain a dark black solid (0.2 g) with a yield of 93.8%.
The structural characterization data of the resulting product are shown below:
1H NMR(400MHz,C6D6)δ7.35(s,1H),6.96(s,1H),5.32(s,1H),2.23(d,J=20.4Hz,4H),1.87–1.54(m,4H),1.37(s,6H),0.87(d,J=6.5Hz,1H),0.35(d,J=42.8Hz,5H).
Example 2:
preparation of photosensitizer 2TPAPT-4F
The synthetic route is as follows:
Synthetic route for photosensitizer 2TPAPT-4F
4-Bromotrianiline (3.24 g,10 mmol) iodine (2.53 g,10 mmol) periodic acid (0.05 g,0.2 mmol) was dissolved in 50mL absolute ethanol and heated to 80℃for 4h, the reaction was cooled to room temperature, the mixture was filtered and the product (2) was used directly in the next reaction. The product of the previous step (2.33 g,3.8 mmol), diphenylamine (1.71 g,10 mmol), cuprous iodide (0.046 g,0.2 mmol), 1.10-phenanthroline (0.043 g,0.2 mmol) and potassium hydroxide (1.71 g,30 mmol) were weighed and reacted in 50mL toluene solution at 120℃for 36h. After cooling to room temperature, the mixture was filtered to remove insoluble impurities. Purification by column chromatography gave 1.2g of the desired product (3). The above product (0.6 g,0.97 mmol), 5-aldehyde-2-thiopheneboronic acid (0.34 g,2.2 mmol), tetrakis (triphenylphosphine) palladium (0.11 g,0.097 mmol), potassium carbonate (0.5 g,3.64 mmol) were weighed into 15mL THF and 15mL water, reacted under nitrogen atmosphere for 24h, cooled to room temperature, and the mixture was filtered to remove insoluble impurities. Purification by column chromatography gave 0.5g of the desired product (4) in 53% yield. 0.2g of the product and 5, 6-difluoro-3- (dicyanomethylene) indigonone (0.18 g,0.79 mmol) were weighed, a few drops of pyridine were added as a catalyst, reacted for 4 hours at 70 ℃, cooled to room temperature, the solvent was evaporated under reduced pressure, the appropriate chloroform was added for dissolution, a large amount of methanol was added to precipitate a solid, and the solid was filtered to obtain a dark black solid (0.2 g) with a yield of 78.9%.
The structural characterization data of the resulting product are shown below:
1H NMR(400MHz,CD2Cl2)δ5.10(d,J=22.3Hz,1H),2.04(s,3H),1.67(s,3H),1.53(s,13H),1.26(s,8H),0.87(d,J=4.1Hz,4H).
Example 3:
Characterization of absorption spectra of A-D-A type photosensitizers (TPAPT-4F and 2 TPAPT-4F)
FIG. 1 is a graph of absorption spectra in THF of materials TPAPT-4F and 2TPAPT-4F obtained in examples 1 and 2, wherein the maximum absorption spectrum of TPAPT-4F in THF solution is 616nm, and the maximum absorption wavelength of 2TPAPT-4F is 640nm, showing that the absorption spectrum is significantly red shifted by enhancing the electron donating ability of electron donating groups, promoting the charge transfer in excited state molecules.
Example 4:
characterization of the emission spectra of type A-D-A photosensitizers (TPAPT-4F and 2 TPAPT-4F)
FIG. 2 is a graph of emission spectra in THF of materials TPAPT-4F and 2TPAPT-4F obtained in examples 1 and 2, with a maximum emission spectrum of TPAPT-4F in THF solution of 910nm and a maximum emission spectrum of 2TPAPT-4F of 977nm, indicating that the strong electron withdrawing effect of fluorine can impart ionic character to the C-F bond, which makes the C-F bond highly polarized, enhances electrostatic interactions between adjacent molecules, and promotes red shift of emission wavelength.
Example 5:
ROS-forming ability of A-D-A type photosensitizers
FIG. 3 is a graph comparing the total active oxygen generating capacity of TPAPT-4F and 2TPAPT-4F, and the photosensitizer Ce 6. The active oxygen probe DCFH, after binding to active oxygen, produced green fluorescence at 522 nm. The molecular concentration was 10. Mu.M in the test, and the optical density was 0.3W/cm -2 by irradiation with a 660nm laser. The results indicate that the TPAPT-4F and 2TPAPT-4F molecules are capable of producing higher fluorescence enhancement factors than Ce6, indicating that the TPAPT-4F and 2TPAPT-4F molecules have a greater ROS production capacity.
Example 6
FIGS. 4 (A) and 4 (C) are graphs of fluorescence spectra under different water content conditions, with the fluorescence intensities of TPAPT-4F and 2TPAPT-4F significantly increasing after gradual addition of water to the THF solution, and FIGS. 4 (B) and 4 (D) are graphs of I/I 0 of TPAPT-4F and 2TPAPT-4F versus water content of the solvent mixture, with PL emissions of TPAPT-4F and 2TPAPT-4F quenched before the critical point (0% water fraction). After the critical point, the fluorescence intensity increased with the addition of water, indicating its aggregation-induced emission characteristics.
Claims (3)
1. An A-D-A type organic small molecule photosensitizer is characterized in that:
wherein X = fluorine or chlorine; ar=aromatic ring electron donating group, any one of the following groups:
2. the use of a class of a-D-a type small organic molecule photosensitizers as claimed in claim 1 for the preparation of imaging agents for cancer cells.
3. The use of a class of small organic molecule photosensitizers as claimed in claim 1 for the preparation of photodynamic therapeutic agents for tumors.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310292719.6A CN116478126B (en) | 2023-03-23 | 2023-03-23 | Preparation and application of A-D-A type organic micromolecular photosensitizer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310292719.6A CN116478126B (en) | 2023-03-23 | 2023-03-23 | Preparation and application of A-D-A type organic micromolecular photosensitizer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116478126A CN116478126A (en) | 2023-07-25 |
CN116478126B true CN116478126B (en) | 2024-10-15 |
Family
ID=87214651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310292719.6A Active CN116478126B (en) | 2023-03-23 | 2023-03-23 | Preparation and application of A-D-A type organic micromolecular photosensitizer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116478126B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108299408A (en) * | 2018-01-23 | 2018-07-20 | 西安近代化学研究所 | Condensed ring A-D-A type conjugated molecules based on carbazole and preparation method thereof |
CN113861392A (en) * | 2021-10-13 | 2021-12-31 | 福州大学 | Fluorenyl cyano indanone non-conjugated polymer receptor and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230276641A1 (en) * | 2020-07-31 | 2023-08-31 | Sony Group Corporation | Photoelectric conversion element and imaging device |
GB2602025A (en) * | 2020-12-15 | 2022-06-22 | Sumitomo Chemical Co | Compound |
-
2023
- 2023-03-23 CN CN202310292719.6A patent/CN116478126B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108299408A (en) * | 2018-01-23 | 2018-07-20 | 西安近代化学研究所 | Condensed ring A-D-A type conjugated molecules based on carbazole and preparation method thereof |
CN113861392A (en) * | 2021-10-13 | 2021-12-31 | 福州大学 | Fluorenyl cyano indanone non-conjugated polymer receptor and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN116478126A (en) | 2023-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ünlü et al. | Preparation of BODIPY-fullerene and monostyryl BODIPY-fullerene dyads as heavy atom free singlet oxygen generators | |
CN112341452A (en) | Compound, preparation method thereof and triplet-triplet annihilation up-conversion system | |
Sarıkaya et al. | Novel BODIPY-Cyclotriphosphazene-Fullerene triads: Synthesis, characterization and singlet oxygen generation efficiency | |
CN107434787A (en) | A kind of preparation, structure and the photoluminescent property of benzimidazole perchlorate | |
CN116478126B (en) | Preparation and application of A-D-A type organic micromolecular photosensitizer | |
CN112358493B (en) | Micromolecular photothermal reagent based on boron-fluorine complex and preparation method and application thereof | |
Drouet et al. | Fluorenyl dendrimer porphyrins: synthesis and photophysical properties | |
CN115819281B (en) | Cyano-substituted p-phenylene ethylene derivative, preparation method and application | |
CN112218855B (en) | NIR-II emissive luminophores | |
CN112079776A (en) | Light-induced crystallized isoquinoline salt compound, preparation method and application thereof, and preparation method of nanocrystal | |
CN112979527B (en) | Halogenimide material with long-wavelength room-temperature phosphorescence emission and application | |
CN105969336B (en) | Triplet-triplet annihilation up-conversion luminescent material based on dendritic polymer structure | |
CN113024586B (en) | Cell membrane targeted BODIPY type organic photosensitizer and application thereof | |
CN110511236B (en) | Fluoroglycopyrrolate photosensitizer and preparation method and application thereof | |
CN113501836A (en) | Star BODIPY near-infrared fluorescent dye and preparation method thereof | |
CN113461698A (en) | Trimeric indenyl dicumarol-corrole triplet photosensitizer and preparation method and application thereof | |
CN115737809B (en) | Preparation of nitrogen heteroatom-containing photosensitizer and tumor photodynamic therapy thereof | |
CN114249758A (en) | Dimer based on five-membered aromatic heterocyclic BODIPY and preparation method thereof | |
CN111961067A (en) | Azo-based dicarbole derivative and preparation method thereof | |
CN114671882B (en) | Tri-indenyl bridged zinc porphyrin-coumarin star-type triplet photosensitizer and preparation method and application thereof | |
CN117865950A (en) | Synthesis and application of strong D-A type organic near infrared two-region luminescent material | |
CN115490631B (en) | Near-infrared thermal activation delayed fluorescence luminescent material based on dicyanophenalene and application thereof | |
CN115109027B (en) | Degradable fluorescent molecule for photodynamic therapy, preparation method and application | |
CN113480550B (en) | Bishydroxycoumarin conjugated porphyrin derivative and preparation method thereof | |
CN112110931B (en) | Axial coordination composite material with two-photon absorption characteristic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |